Login / Signup

Elimination of 15N-thymidine after oral administration in human infants.

Niyatie AmmanamanchiJessie YesterAnita P BargajeDawn ThomasKathryn C LittleShannon JanzefKimberly FrancisJacqueline WeinbergJennifer JohnsonThomas SeeryTyler Hutchinson HarrisBryan J FunariKirsten Rose-FelkerMatthew ZinnSusan A MillerShawn C WestBrian FeingoldHairu ZhouMatthew L SteinhauserTimothy CsernicaRobert MichenerBernhard Kühn
Published in: PloS one (2024)
The presented results support two conclusions of significance for future applications: (1) Demonstration that 15N-thymidine label administration at home is equivalent to in-hospital administration. (2) Two different types of heart disease show no differences in 15N-thymidine absorption and elimination. This enables the comparative analysis of cellular proliferation between different types of heart disease.
Keyphrases
  • pulmonary hypertension
  • endothelial cells
  • healthcare
  • signaling pathway
  • current status
  • induced pluripotent stem cells
  • emergency department
  • adverse drug